tirzepatide menopause New research from a Mayo Clinic–led study suggests that postmenopausal women using hormone therapy may experience greater weight loss when treated with tirzepatide, a GLP-1–based medication for overweight and obesity. In Tirzepatide and Menopause| Listen to

Assessing Glutathione Demand At Elemental Health and Nutrition, assessment extends beyond thyroid-stimulating hormone (TSH) alone and includes functional testing to understand antioxidant demand and methylation capacity: Thyroid antibodies (TPO, TgAb): Indicators of immune activity against thyroid tissue and potential markers of oxidative stress burden

Continuing semaglutide at a lower dose after reaching your goal weight can help maintain cardioprotective and anti-inflammatory benefits, supporting sustained results and overall metabolic health

Endocrinology, 164(6), 1056-1066

Sip the rest of the smoothie instead of the hair of the dog

Massage the cream in with your fingertips until all the product has been absorbed